A phase I study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of suraxavir marboxil: a novel oral antiviral for influenza. (journals.asm.org)

Authors: Zhou J … Wang N Journal: Antimicrobial Agents and Chemotherapy Published: 2026-05-06 DOI: https://doi.org/10.1128/aac.01668-25